San Carlos, CA, United States of America

Roopa Rai

This inventor holds 22 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Medivation Technologies, Inc., Pharmacyclics, Inc., Myoforte Therapeutics, Inc.. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roopa Rai. Retrieved from https://idiyas.com/inventor/roopa-rai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 15)

% Patents Active = 72.7

CIPO Patents = 1 (Patent Applications = 12)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 111(Granted Patents)

Location History:

San Francisco, CA (US) (2017 - 2023)
San Carlos, CA (US) (2005 - 2024)

Company Filing History:

8 out of 63

Medivation Technologies, Inc.

Myoforte Therapeutics, Inc.

patents

4. 1 out of 40

Axys Pharmaceuticals, Inc.

Smithkline Beecham Corporation

patents

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

PGDH Inhibitors

MYST Acetyl Transferases

Factor VIIa Inhibitor

Heterocyclic Compounds

Fused Pyrimidine Compounds

Anti-Viral Compounds

Protease Inhibitors

Compounds and Methods

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559493 - PGDH inhibitors and methods of making and using (2026-02-24),

2. 12187732 - Inhibitors of the myst family of lysine acetyl transferases (2025-01-07),

3. 11976075 - Inhibitors of the MYST family of lysine acetyl transferases (2024-05-07),

4. 11891389 - PGDH inhibitors and methods of making and using (2024-02-06),

5. 11702401 - Compounds and methods of use (2023-07-18),

6. 11345702 - PGDH inhibitors and methods of making and using (2022-05-31),

7. 11053216 - Compounds and methods of use (2021-07-06),

8. 10501436 - Compounds and methods of use (2019-12-10),

9. 10189826 - Heterocyclic compounds and methods of use (2019-01-29),

10. 10030004 - Compounds and methods of use (2018-07-24),

11. 9670172 - Heterocyclic compounds and methods of use (2017-06-06),

12. 9499519 - Fused pyrimidine compounds and use thereof (2016-11-22),

13. 9422267 - Fused pyrimidine compounds and use thereof (2016-08-23),

14. 9181280 - Factor VIIa inhibitor (2015-11-10),

15. 9162986 - [object Object] (2015-10-20),

Title: Roopa Rai: Innovator in the Pharmaceuticals Industry

Introduction

Roopa Rai, based in San Carlos, California, is an accomplished inventor with a remarkable portfolio of 21 patents. His innovative contributions primarily focus on the field of pharmaceuticals, specifically the development of compounds that target critical enzymes implicated in cancer.

Latest Patents

Among Roopa's latest inventions are inhibitors of the MYST family of lysine acetyltransferases. These compounds, described in his patents through Formula (I), present methods for synthesis and intermediates essential for the preparation of these inhibitors. The significance of these compounds lies in their potential application in preventing or treating hyperproliferative diseases, particularly cancer. Specifically, they target KAT6A and KAT6B - enzymes often mutated and overexpressed in various cancer types, thus altering their normal functions. The practical use of these compounds extends to the formulation of pharmaceutical compositions, potentially enhancing cancer treatment efficacy when combined with other anti-cancer agents.

Career Highlights

Roopa Rai has a profound impact on the pharmaceutical sector, with tenure at notable companies like Medivation Technologies, Inc. and Pharmacyclics, Inc. His work has contributed significantly to advancements in therapeutic agents aimed at combating cancer and related disorders.

Collaborations

During his career, Roopa has collaborated with esteemed professionals, including William Dvorak Shrader and Sarvajit Chakravarty. These collaborations have fostered innovation and expanded the impact of his work on the pharmaceutical landscape.

Conclusion

Roopa Rai's contributions to the field of medical science exemplify the potential of innovation in addressing complex health challenges like cancer. His extensive patent portfolio not only reflects his commitment to research but also underscores the critical nature of his work in the development of novel therapeutic agents. As the fight against cancer continues, inventors like Roopa play a vital role in paving the way for future breakthroughs.

Profile summary based on public USPTO records.